Parker Institute and Cancer Vaccine Coalition Unite to Accelerate Cancer Treatments

Kristen Dahlgren joins PICI as Chief External Affairs Officer to drive cancer vaccine development

Apr. 14, 2026 at 12:11pm by

Got story updates? Submit your updates here. ›

A minimalist neon outline of a human cell, with glowing lines tracing its internal structures, conceptually representing the groundbreaking cancer research being conducted.The strategic integration of cancer research leaders aims to accelerate the development of innovative immunotherapies that could transform cancer treatment.San Francisco Today

The Parker Institute for Cancer Immunotherapy (PICI) has announced a strategic integration with the Cancer Vaccine Coalition, a nonprofit dedicated to advancing next-generation cancer immunotherapies. This partnership aims to accelerate the development and delivery of cancer vaccines, which are seen as one of the most promising frontiers in cancer research.

Why it matters

Cancer vaccines represent a major breakthrough in cancer treatment, offering the potential to prevent and even cure certain types of cancer. By combining the resources and expertise of PICI and the Cancer Vaccine Coalition, this integration will allow for more groundbreaking discoveries and faster delivery of these innovative treatments to patients.

The details

The integration will see Kristen Dahlgren, the founder of the Cancer Vaccine Coalition and a former NBC correspondent, join PICI as the Chief External Affairs Officer. This will allow the combined entity to support more cancer vaccine research and bring these treatments to patients more quickly.

  • The partnership was announced on April 14, 2026.

The players

Parker Institute for Cancer Immunotherapy (PICI)

A nonprofit organization dedicated to advancing cancer immunotherapy research and development.

Cancer Vaccine Coalition

A nonprofit dedicated to advancing next-generation cancer immunotherapies, including cancer vaccines.

Kristen Dahlgren

The founder of the Cancer Vaccine Coalition and a former NBC correspondent, who will join PICI as the Chief External Affairs Officer.

Got photos? Submit your photos here. ›

What’s next

The integration of PICI and the Cancer Vaccine Coalition is expected to lead to increased funding and resources for cancer vaccine research, as well as the acceleration of clinical trials and the delivery of these treatments to patients.

The takeaway

This partnership represents a significant step forward in the fight against cancer, as it combines the expertise and resources of two leading organizations in the field of cancer immunotherapy. The focus on cancer vaccines, a promising new frontier in cancer treatment, holds the potential to transform the way we prevent and treat this devastating disease.